Modern Health vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 41)
Modern Health logo

Modern Health

EmergingHealthcare

Mental Health Benefits

Modern Health is an enterprise mental health platform providing personalized therapy, coaching, and wellbeing resources to employees through employer-sponsored benefits programs. HQ: San Francisco.

AI VisibilityBeta
Overall Score
C41
Category Rank
#348 of 596
AI Consensus
75%
Trend
stable
Per Platform
ChatGPT
46
Perplexity
41
Gemini
37

About

Modern Health is an enterprise mental health platform that provides employees access to licensed therapists, mental health coaches, and digital wellness resources through their employer-sponsored benefits. Founded in 2017 by Alyssa Jaffee and Erica Johnson, Modern Health delivers a clinically validated mental health benefit that employers offer to their workforce as part of comprehensive health benefits packages — giving employees same-week access to therapy and coaching rather than waiting months for a mental health appointment through traditional insurance.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

41
Overall Score
90
#348
Category Rank
#2
75
AI Consensus
83
stable
Trend
stable
46
ChatGPT
92
41
Perplexity
93
37
Gemini
89
46
Claude
96
39
Grok
95

Key Details

Category
Mental Health Benefits
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Modern Health
Mental Health Benefits

Integrations

Only Moderna
Moderna is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.